スキンブースターの市場規模、シェア、成長分析、タイプ別、性別、最終用途別、地域別-産業予測、2025～2032年

スキンブースターの2023年の市場規模は1兆748億2,000万米ドルで、2024年の1兆1,726億3,000万米ドルから2032年には2兆3,537億5,000万米ドルに成長し、予測期間（2025～2032年）のCAGRは9.1％で成長する見通しです。

世界のスキンブースター市場は、スキンケアと美容強化に対する消費者の関心の高まりに後押しされ、力強い成長軌道に乗っています。ヒアルロン酸を主成分とするこれらの低侵襲性美容注入剤は、最小限のダウンタイムで自然な結果をもたらす非外科的処置の需要に応えるものです。皮膚疾患の発生率の上昇と並んで、加齢による衰えを防ごうとする高齢化人口の急増が、市場の関心を大きく引き寄せています。技術の進歩により、革新的な製剤と優れた投与方法が開発され、治療の有効性と安全性が向上しています。北米は現在、高い個人消費と強力なヘルスケア・インフラに支えられて市場を独占していますが、アジア太平洋地域が可処分所得の増加と美の基準の変化により急速に台頭しています。規制の精査やコストの障壁といった課題にもかかわらず、スキンブースター市場は、継続的な技術革新と顧客層の拡大に支えられ、今後も成長すると予想されています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• スタートアップ分析
• 特許分析
• 貿易分析

スキンブースターの市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• メソセラピー
  • ヒアルロン酸
  • ビタミン
  • ミネラル
• マイクロニードル
  • 皮膚フィラー
  • 多血小板血漿（PRP）

スキンブースターの市場規模：性別& CAGR（2025-2032）

• 市場概要
• 女性
• 男性

スキンブースターの市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 皮膚科クリニック
• メディスパ

スキンブースターの市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Galderma S.A.（Switzerland）
• Merz Aesthetics（Germany）
• Bloomage Biotechnology Corporation Limited（China）
• Teoxane Laboratories（Switzerland）
• Filorga（France）
• Professional Derma SA（Switzerland）
• IBSA-Institute Biochemical SA（Switzerland）
• Revance Therapeutics, Inc.（USA）
• Suneva Medical, Inc.（USA）
• Anika Therapeutics, Inc.（USA）
• Prollenium Medical Technologies Inc.（Canada）
• Revitrane（South Korea）
• Caregen Co., Ltd.（South Korea）
• Hugel, Inc.（South Korea）
• Daewoong Pharmaceutical Co., Ltd.（South Korea）
• LG Chem Ltd.（South Korea）
• Hyundai Bioscience Co., Ltd.（South Korea）
• Medytox Inc.（South Korea）
• Croma-Pharma GmbH（Austria）

結論と推奨事項

Skin Boosters Market size was valued at USD 1074.82 Billion in 2023 and is poised to grow from USD 1172.63 Billion in 2024 to USD 2353.75 Billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).

The global skin booster market is on a robust growth trajectory, propelled by heightened consumer interest in skincare and aesthetic enhancements. These minimally invasive cosmetic injectables, primarily composed of hyaluronic acid, cater to the demand for non-surgical procedures that deliver natural results with minimal downtime. The surge in the aging population seeking to combat signs of aging, alongside a rising prevalence of skin conditions, is significantly driving market interest. Technological advancements have led to innovative formulations and superior delivery methods, enhancing treatment efficacy and safety. North America currently dominates the market, fueled by high consumer spending and a strong healthcare infrastructure, while the Asia-Pacific region is rapidly emerging due to increasing disposable income and changing beauty norms. Despite challenges like regulatory scrutiny and cost barriers, the skin booster market is expected to flourish, underpinned by ongoing innovation and an expanding client base.

Top-down and bottom-up approaches were used to estimate and validate the size of the Skin Boosters market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Skin Boosters Market Segmental Analysis

Global Skin Boosters Market is segmented by type, gender, end-use and region. Based on type, the market is segmented into mesotherapy and micro-needle. Based on gender, the market is segmented into female and male. Based on end-use, the market is segmented into dermatology clinics and medspa. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Skin Boosters Market

The Skin Boosters market is being driven by a growing desire among individuals to maintain a youthful and photogenic appearance. The COVID-19 pandemic and the rise of remote work have significantly increased the demand for wrinkle treatments as more people participate in virtual meetings and interviews, where a polished look is essential. Social media platforms, particularly Instagram and Facebook, amplify this trend, pushing individuals to enhance their skincare for better online representation. Additionally, the influence of online personalities who share lifestyle and beauty tips has further fueled this enthusiasm. Industry leaders are tapping into this phenomenon by collaborating with popular influencers to effectively market their skincare solutions.

Restraints in the Skin Boosters Market

The Skin Boosters market is hindered by several restraints, primarily revolving around high product costs and limited penetration among consumers. The expense associated with these treatments is a major challenge, as prices are shaped by the practitioner's expertise, the techniques used, and the overall complexity of the procedure. Additionally, since skin boosters offer temporary results, clients may find themselves needing further treatments down the line, adding to their financial commitment. This potential for ongoing costs can discourage many individuals from pursuing these options, leading them to prefer more affordable skincare alternatives that do not involve injections or invasive procedures.

Market Trends of the Skin Boosters Market

The Skin Boosters market is witnessing a significant trend driven by an increasing emphasis on preventive skincare among consumers. As individuals become more health-conscious and seek to maintain youthful, radiant skin, there's a growing adoption of skin boosters known for their ability to enhance hydration, improve elasticity, and combat early signs of aging. This proactive approach signifies a shift in consumer behavior, favoring treatments that not only address existing skin concerns but also serve as a long-term investment in skin health. As a result, the demand for innovative and effective skin booster products is rapidly expanding, shaping the future of skincare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Startup Analysis
• Patent Analysis
• Trade Analysis

Global Skin Boosters Market Size by Type & CAGR (2025-2032)

• Market Overview
• Mesotherapy
  • Hyaluronic Acid
  • Vitamins
  • Minerals
• Micro-Needle
  • Dermal Fillers
  • Platelet-Rich Plasma (PRP)

Global Skin Boosters Market Size by Gender & CAGR (2025-2032)

• Market Overview
• Female
• Male

Global Skin Boosters Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Dermatology Clinics
• MedSpa

Global Skin Boosters Market Size & CAGR (2025-2032)

• North America (Type, Gender, End-Use)
  • US
  • Canada
• Europe (Type, Gender, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Gender, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Gender, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Gender, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Galderma S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz Aesthetics (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bloomage Biotechnology Corporation Limited (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teoxane Laboratories (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Filorga (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Professional Derma SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBSA - Institute Biochemical SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revance Therapeutics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Suneva Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anika Therapeutics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prollenium Medical Technologies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revitrane (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caregen Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hugel, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daewoong Pharmaceutical Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LG Chem Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hyundai Bioscience Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medytox Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Croma-Pharma GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations